Celebrating 25 Years of Scoop
Special: Up To 25% Off Scoop Pro Learn More
Parliament

Gordon Campbell | Parliament TV | Parliament Today | Video | Questions Of the Day | Search

 

Breakthrough pharmaceutical R&D project for NZ


Breakthrough pharmaceutical R&D project for NZ

Technology New Zealand is granting almost $1.7 million to a ground-breaking research and development project that will increase the capacity in New Zealand to commercialise newly discovered pharmaceuticals.

The funding, Technology New Zealand's largest ever R&D grant, has been awarded to Auckland company Antipodean Biotechnology Limited. Antipodean is working with seven of New Zealand’s leading research institutes to develop a new substance, mitoquinone, for treating Friedreich’s Ataxia and Huntington’s Disease, for which no treatments currently exist.

"This is the first time a drug discovered in this country will also be manufactured, formulated into tablets, tested for absorption, metabolism and safety before proceeding to the first patient studies, all within New Zealand," Mr Hodgson said.

"This is a very significant development for New Zealand's prospects as a place for pharmaceutical research and development. We have people with the talent to develop new drugs, but the expertise is dispersed and the ability to commercialise new discoveries has been limited. By bringing that expertise together with this project, Antipodean is putting New Zealand on the map as a source of pharmaceutical innovation.”

The total project is costing $3.34 million, with Antipodean matching dollar for dollar the funds contributed by Technology New Zealand. Further private funding will be needed for the project's later stages.

Antipodean is a seed venture capital company set up to fund the development and commercialisation of new pharmaceuticals discovered in New Zealand, using New Zealand expertise and facilities. It intends to work with an overseas partner to complete the development process and eventually market the product globally.

Technology New Zealand is part of the Foundation for Research, Science and Technology and invests in research and development projects which result in new products, processes or services. Its largest previous grant was $900,000 to Auckland company Navman.


Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Parliament Headlines | Politics Headlines | Regional Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 
 

InfoPages News Channels


 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.